Skip to main content

Table 2 SF-36 Health Survey Scores Before and After the Cardio-Oncology Risk Reduction Program

From: Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

SF-36 Sub-Scale Measures Baseline Follow-up Difference Effect Size P-value
Physical Functioning 47.7 ± 9.8 44.3 ± 12.3 −3.4 ± 9.0 −0.38 0.07
Physical Role 42.6 ± 12.5 39.9 ± 13.9 −2.7 ± 14.3 −0.19 0.30
Bodily Pain 45.2 ± 9.5 44.3 ± 11.6 −0.8 ± 12.1 −0.07 0.48
General Health Perception 44.9 ± 10.1 42.6 ± 10.5 −2.3 ± 11.1 −0.21 0.26
Mental Health 44.3 ± 13.3 49.4 ± 11.6 5.1 ± 10.8 0.47 0.004
Emotional Role Limitations 45.6 ± 13.4 47.8 ± 12.6 2.2 ± 11.5 0.19 0.21
Social Functioning 44.9 ± 13.1 42.6 ± 12.6 −2.3 ± 13.4 −0.17 0.36
Vitality/Energy 47.3 ± 11.8 44.8 ± 13.4 −2.5 ± 11.2 −0.22 0.23
Physical Component Summary (PCS) 46.2 ± 9.9 40.9 ± 11.9 −5.4 ± 10.2 −0.53 0.005
Mental Component Summary (MCS) 45.0 ± 14.0 48.8 ± 11.5 3.8 ± 10.4 0.37 0.02
  1. Values listed as means ± standard deviation; Bold indicates statistical significance result